Physician profile
Melody E Ronk
NPI 1851513725
$5,135.12
in general payments reported to CMS, 2019-2025
43 companies · $1,258 in 2025
The $1,258 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,164 · 2022: $1,030 · 2023: $738 · 2024: $946 · 2025: $1,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,941.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $886.13 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $716.46 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Novo Nordisk INC | $651.05 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $448.78 | 2021-2025 | |
| Amgen INC. | $360.78 | 2021-2025 | Otezla, Repatha, Krystexxa |
| Lilly USA, LLC | $293.99 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Pfizer INC. | $189.15 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $134.84 | 2021-2025 | Rexulti |
| Exact Sciences Corporation | $90.81 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boston Scientific Corporation | $80.55 | 2023-2025 | Wavewriter Alpha Prime 16, General - Therapies |
| Biohaven Pharmaceuticals, INC. | $80.39 | 2021 | |
| Seqirus USA INC | $80.09 | 2024-2025 | Flucelvax, Fluad |
| Takeda Pharmaceuticals U.S.A., INC. | $77.55 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $73.64 | 2022 | |
| Glaxosmithkline, LLC. | $68.36 | 2021-2025 | Shingrix, Arexvy |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Ronk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.